Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

CJM-112

Catalog No. T9901A-1036 Copy Product Info
🥰Excellent
CJM-112 is a humanized monoclonal antibody inhibitor that targets interleukin-17A (IL-17A). It holds potential for research in inflammatory diseases, such as hidradenitis suppurativa, which involve abnormalities in the IL-17A-related pathway.

CJM-112

Copy Product Info
🥰Excellent
Catalog No. T9901A-1036

CJM-112 is a humanized monoclonal antibody inhibitor that targets interleukin-17A (IL-17A). It holds potential for research in inflammatory diseases, such as hidradenitis suppurativa, which involve abnormalities in the IL-17A-related pathway.

CJM-112
Pack SizePriceUSA StockGlobal StockQuantity
1 mgInquiryInquiryInquiry
5 mgInquiryInquiryInquiry
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
CJM-112 is a humanized monoclonal antibody inhibitor that targets interleukin-17A (IL-17A). It holds potential for research in inflammatory diseases, such as hidradenitis suppurativa, which involve abnormalities in the IL-17A-related pathway.
Reactivity
Human
Application
FACS
Functional assay
Antibody Type
Monoclonal
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Chemical Properties
Storage & Solubility Information
StorageStore at low temperature | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator
Related Tags: buy CJM-112 | purchase CJM-112 | CJM-112 cost | order CJM-112